Anti-tau antibody Semorinemab fails to slow Alzheimer's disease progression: JAMA Dr. Hiral patel22 Jun 2022 4:15 AMUSA: A 73-week, phase 2, randomized clinical trial data published in JAMA Neurology showed that semorinemab did not slow clinical AD progression ...
Ultrahigh-dose methylcobalamin was efficacious in Amyotrophic Lateral Sclerosis: JAMA Dr. Shravani Dali19 Jun 2022 2:30 PMUltrahigh-dose methylcobalamin was efficacious in slowing functional decline in patients with early-stage ALS and with moderate progression rate...
Fenfluramine reduces seizure occurrence in patients with Lennox-Gastaut syndrome, JAMA says Medical Dialogues Editorial Team9 May 2022 4:15 AMAustralia: Fenfluramine, as compared to placebo, offered a considerably higher reduction in drop seizures in individuals with Lennox-Gastaut syndrome...
Loss of smell in COVID-19 infection due to inflammation and not direct action of virus Dr. Kamal Kant Kohli3 May 2022 5:45 AMAnosmia, the loss of smell, is a frequent and often long-term symptom associated with COVID-19 that can severely burden a person's quality of life,...
Intensive BP control tied to increase in whole-brain cerebral blood flow Medha Baranwal30 April 2022 3:30 AMUSA: Intensive antihypertensive treatment compared to the standard one is associated with increased, rather than decreased, cerebral perfusion,...
Vision improvement may cut prevalence of Dementia: study Dr. Shravani Dali27 April 2022 3:45 AMDementia Prevalence May Be Reduced by Improving Vision, according to a recent study published in the JAMA Neurology. Dementia prevention is a high...
Photon-counting CT helpful in better visulaization of CSF venous fistula: Study Medha Baranwal25 April 2022 3:30 AMUSA: Cerebrospinal fluid (CSF) venous fistula (CVF) is better visualized by photon-counting CT (PCCT) than traditional imaging approaches such as CT...
JAMA: IV Immunoglobulin shown to lower MOGAD relapse in adults Medical Dialogues Editorial Team12 April 2022 3:30 AMUSA: In a new study conducted by John J. Chen and team showed that in adult patients with myelin oligodendrocyte glycoprotein antibody - associated...
Lamotrigine and levetiracetam reasonable first-line treatment options for patients with poststroke epilepsy: JAMA Medical Dialogues Editorial Team6 April 2022 3:30 AMSweden: Recent research found disparities in survival among individuals treated with various antiseizure medications (ASM) for poststroke epilepsy....
Tourette syndrome patients at risk of assault or exhibition of criminal behavior: JAMA Medha Baranwal25 March 2022 4:00 AMSweden: Patients with Tourette syndrome (TS) or chronic tic disorder (CTD) diagnosed in specialist settings are more likely to experience assault or...
Epilepsy and hearing loss early signs of Parkinson Disease finds JAMA study Medical Dialogues Editorial Team22 March 2022 3:30 AMUK: In a new study conducted by Cristina Simonet and the team, new temporal correlations between epilepsy and hearing loss and the development of...
19/March/2022 Top Medical Bulletin Dr. Nandita Mohan19 March 2022 12:45 PMHere are top medical stories for today:Intensive blood pressure control associated with cerebral blood flow The association of intensive...
